At close: December 20 at 4:00:03 PM EST
After hours: 7:58:25 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,454.00
-18,728.00
-11,511.00
-12,252.00
-9,185.00
Investing Cash Flow
9,483.00
-18,299.00
11,538.00
-20,537.00
-16,134.00
Financing Cash Flow
11,873.00
36,842.00
-6.00
30,087.00
28,845.00
End Cash Position
4,134.00
4,543.00
4,728.00
4,707.00
7,409.00
Income Tax Paid Supplemental Data
27.00
33.00
27.00
28.00
36.00
Interest Paid Supplemental Data
--
--
--
--
2.00
Capital Expenditure
-21.00
-24.00
-81.00
-22.00
-47.00
Issuance of Capital Stock
11,747.00
36,848.00
--
29,849.00
28,805.00
Repayment of Debt
-7.00
-6.00
-6.00
-6.00
-5.00
Free Cash Flow
-19,475.00
-18,752.00
-11,592.00
-12,274.00
-9,232.00
12/31/2020 - 8/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMR.SG AC Immune SA
2.5700
-2.84%
EU6.F PDS Biotechnology Corporation
1.6680
-3.30%
CRTHF CARsgen Therapeutics Holdings Limited
0.7465
0.00%
CY71.F Anixa Biosciences, Inc.
2.5600
+6.67%
IUL.BE ImmuCell Corp
4.3600
+3.32%
6JH.SG IN8bio Inc
0.2280
-10.24%
6JH.BE IN8bio Inc
0.2340
-2.50%
XI3.F Bioceltix S.A.
16.46
+0.98%
174900.KQ AbClon Inc.
13,760.00
-1.92%
S09.F Sutro Biopharma, Inc.
1.7000
-9.09%